Afinitor Tablet
Product Images NDC 0078-0566

Product Visual Gallery

This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Afinitor (NDC 0078-0566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Everolimus Structural Formula (Afinitor 01)

Chemical structure diagram of everolimus, the active ingredient in Afinitor. The diagram shows a complex molecular structure with multiple rings, oxygen and methyl groups characteristic of this immunosuppressant drug molecule.*

FDA Label Image

Figure 2: Kaplan-meier Investigator-determined Progression-free Survival Curves (Afinitor 02)

Kaplan-Meier survival curve comparing Afinitor (everolimus) versus placebo over 28 months, illustrating probability (%) on the y-axis and time (months) on the x-axis. The chart includes hazard ratio, confidence interval, logrank p value, median survival times for Afinitor and placebo, and denotes censoring times and sample sizes for both groups.*

FDA Label Image

Figure 4: Kaplan-meier Progression-free Survival Curves (Afinitor 03)

A Kaplan-Meier survival curve comparing Afinitor (everolimus) tablets versus placebo over time in months, showing probability percentage on the y-axis. The chart includes hazard ratio, confidence intervals, logrank p value, median survival times for each group, and indicates censoring times with markers.*

FDA Label Image

Principal Display Panel Ndc 0078-0594-51 Rx Only 28 Tablets Carton Contains 4 Individual Blister Cards Of 7 Tablets. Afinitor® (everolimus) Tablets Each Tablet Contains 2.5 mg Everolimus Novartis (Afinitor 04)

Carton label for Afinitor (everolimus) tablets, 2.5 mg strength. The box contains 28 tablets, arranged as 4 individual blister cards of 7 tablets each. The label includes storage instructions, manufacturer Novartis Pharmaceuticals Corporation, and contact information for further support. The NDC code 0078-0594-51 is visible along with a barcode and regulatory information.*

FDA Label Image

Principal Display Panel Ndc 0078-0566-51 Rx Only 28 Tablets Carton Contains 4 Individual Blister Cards Of 7 Tablets. Afinitor® (everolimus) Tablets Each Tablet Contains 5 mg Everolimus Novartis (Afinitor 05)

Packaging label for Afinitor (everolimus) tablets, each containing 5 mg of everolimus. The carton includes 28 tablets supplied as 4 blister cards of 7 tablets each. The label shows the Novartis Pharmaceuticals Corporation logo and provides storage instructions along with distributor information. NDC 0078-0566-51, Rx only.*

FDA Label Image

Principal Display Panel Ndc 0078-0567-51 Rx Only 28 Tablets Carton Contains 4 Individual Blister Cards Of 7 Tablets. Afinitor® (everolimus) Tablets Each Tablet Contains 10 mg Everolimus Novartis (Afinitor 06)

Packaging label for Afinitor (everolimus) tablets, 10 mg strength. The label shows a carton containing 28 tablets, distributed by Novartis Pharmaceuticals Corporation. The label includes dosage form as oral tablets and features product branding, strength, and quantity information along with storage instructions and manufacturer details.*

FDA Label Image

Principal Display Panel Ndc 0078-0620-51 Rx Only 28 Tablets Carton Contains 4 Individual Blister Cards Of 7 Tablets. Afinitor® (everolimus) Tablets Each Tablet Contains 7.5 mg Everolimus Novartis (Afinitor 07)

Carton packaging label for Afinitor (everolimus) tablets, 7.5 mg strength. The label indicates the box contains 28 tablets packaged in 4 individual blister cards of 7 tablets each. The product is labeled for prescription use only and is distributed by Novartis Pharmaceuticals Corporation.*

FDA Label Image

Figure 1: Kaplan-meier Progression-free Survival Curves (investigator Radiological Review) (Afinitor 08)

A Kaplan-Meier survival curve graph showing progression-free survival probability (%) over time in months for two groups: patients treated with Everolimus 10 mg plus exemestane and those given a placebo plus exemestane. The graph includes censoring times and shows higher survival probability for the Everolimus group compared to placebo.*

FDA Label Image

Principal Display Panel Ndc 0078-0626-51 Rx Only 28 Tablets For Oral Suspension Carton Contains 4 Individual Blister Cards Of 7 Tablets. Afinitor Disperz® (everolimus Tablets For Oral Suspension) 2 mg Tablets Must Be Dispersed In Water. Tablets Must Not Be Swallowed Whole, Chewed Or Crushed. Each Tablet Contains 2 mg Everolimus Novartis (Afinitor 09)

Packaging label for Afinitor Disperz 2 mg tablets for oral suspension containing everolimus. The label shows a carton containing 28 tablets divided into 4 blister cards of 7 tablets each. Labeler is Novartis Pharmaceuticals Corporation, product of Switzerland. Instructions indicate tablets must be dispersed in water and not swallowed whole, chewed, or crushed.*

FDA Label Image

Figure A (Afinitor 0a)

An instructional diagram of a syringe showing labeled parts including the tip, volume indicators, barrel, and plunger. The volume scale on the barrel ranges from 1 to 10 milliliters.*

FDA Label Image

Figure B (Afinitor 0b)

An instructional illustration showing a person washing their hands under running water from a faucet, with soap lather visible on the hands. The image emphasizes proper handwashing technique.*

FDA Label Image

Figure C (Afinitor 0c)

An illustration showing a hand putting on a disposable glove, with fingers extended and the glove being pulled over the wrist by the opposite hand. This instructional image likely demonstrates proper glove wearing technique.*

FDA Label Image

Figure D (Afinitor 0d)

An illustration showing two oral syringes used for measuring and administering liquid medication. One syringe is shown with its plunger extended, and the other shows clear volume markings from 1 ml to 10 ml.*

FDA Label Image

Figure E (Afinitor 0e)

An instructional diagram showing a pair of hands using scissors to cut a blister pack containing multiple tablets. The image demonstrates how to separate individual doses or smaller portions of the medication packaging.*

FDA Label Image

Figure F (Afinitor 0f)

An instructional illustration showing two hands placing a tablet into a small vial or container. One hand holds the container steady while the other hand drops the tablet inside. An arrow indicates the downward motion of the tablet into the container.*

FDA Label Image

Figure G (Afinitor 0g)

An instructional diagram showing a hand holding a pencil-like device above an open test tube or container. The device appears to be dispensing or inserting a small object into the container, indicated by a downward arrow. The illustration focuses on demonstrating the correct technique for this action.*

FDA Label Image

Figure H (Afinitor 0h)

An instructional black-and-white illustration showing a hand holding a syringe, with the thumb pulling back on the plunger, indicated by an arrow. The image likely demonstrates how to withdraw or draw medication into the syringe.*

FDA Label Image

Figure I (Afinitor 0i)

An instructional illustration showing a hand holding a tube with tablets inside, submerged into a glass of liquid. A close-up inset highlights the effervescent tablets dissolving at the tube's opening underwater, indicating a method of dissolving the medication before use.*

FDA Label Image

Figure J (Afinitor 0j)

An instructional diagram showing a hand holding a syringe with liquid inside, positioned above a finger. An inset magnifies the syringe tip indicating an air bubble labeled 'Air' above the liquid level. The illustration likely demonstrates a technique related to syringe preparation or injection.*

FDA Label Image

Figure K (Afinitor 0k)

An instructional illustration showing a syringe or dropper placed inside a glass containing liquid, accompanied by a clock indicating a time interval of 3 minutes. The image likely demonstrates a timing instruction or waiting period related to medication administration or preparation.*

FDA Label Image

Figure L (Afinitor 0l)

An instructional illustration showing two hands holding a syringe and instructions to shake or invert it 5 times, indicated by circular arrows between the hands and the text '5 times' below.*

FDA Label Image

Figure M (Afinitor 0m)

An instructional illustration showing a hand holding a syringe with an upward arrow, indicating a step in preparing or using the syringe. The image depicts technique or handling of the syringe, without additional text or branding.*

FDA Label Image

Figure N (Afinitor 0n)

An instructional illustration showing a hand holding and inserting an oral syringe into an open mouth, demonstrating the correct technique for oral administration of medication.*

FDA Label Image

Figure O (Afinitor 0o)

An instructional diagram showing a person using a syringe to inject a substance into a clear glass of liquid, demonstrating the mixing or dilution process. The image includes a close-up inset focusing on the syringe tip entering the liquid surface.*

FDA Label Image

Figure P (Afinitor 0p)

An instructional diagram depicting hands holding a syringe, illustrating air expulsion from the syringe by pointing the needle upward and tapping to remove air before injection. The close-up inset highlights the air bubble at the top inside the syringe barrel.*

FDA Label Image

Figure Q (Afinitor 0q)

An instructional illustration showing a gloved hand holding a syringe. The image depicts an arrow indicating a circular motion, suggesting the action of mixing or drawing medication within the syringe barrel. No specific product labeling or dosage information is visible.*

FDA Label Image

Figure R (Afinitor 0r)

An instructional illustration showing a hand holding a syringe vertically, with an arrow pointing upward, likely demonstrating the correct technique to hold or prepare the syringe. No product or dosage information is shown.*

FDA Label Image

Figure S (Afinitor 0s)

An instructional illustration showing a hand administering oral medication with a syringe into a person's mouth. The person’s open mouth is visible on the left, and the syringe is positioned near the lips with an arrow indicating the direction of syringe movement for dosing.*

FDA Label Image

Figure T (Afinitor 0t)

An instructional diagram showing a pair of hands being washed under running water from a faucet, demonstrating hand hygiene technique.*

FDA Label Image

Figure U (Afinitor 0u)

An illustration showing a hand pulling on a disposable glove, demonstrating the proper technique for putting on protective gloves, likely to avoid contamination or exposure during handling of medication.*

FDA Label Image

Figure V (Afinitor 0v)

An instructional illustration showing a medicine cup with volume markings at 5, 10, 20, and 30 milliliters. Text beside the cup indicates "25 mL of water," highlighting a liquid measurement for use, likely as a preparation or administration instruction.*

FDA Label Image

Figure W (Afinitor 0w)

An instructional illustration showing a hand holding a marked measuring cup pouring liquid into a drinking glass, indicating a dosing or medication preparation step.*

FDA Label Image

Figure X (Afinitor 0x)

An instructional illustration showing hands using scissors to cut a medication blister pack into individual tablet sections. The blister contains printed text panels that appear to include drug information and safety data for a prescription medication.*

FDA Label Image

Figure Y (Afinitor 0y)

An instructional illustration depicting a hand dropping a tablet into a glass of water with an arrow indicating the tablet going into the water.*

FDA Label Image

Figure Z (Afinitor 0z)

An illustration showing a glass with two tablets dissolving in water next to a timer indicating 3 minutes. The image visually suggests allowing tablets to dissolve for three minutes before use.*

FDA Label Image

Principal Display Panel Ndc 0078-0627-51 Rx Only 28 Tablets For Oral Suspension Carton Contains 4 Individual Blister Cards Of 7 Tablets. Afinitor Disperz® (everolimus Tablets For Oral Suspension) 3 mg Tablets Must Be Dispersed In Water. Tablets Must Not Be Swallowed Whole, Chewed Or Crushed. Each Tablet Contains 3 mg Everolimus Novartis (Afinitor 10)

Packaging label for Afinitor Disperz 3 mg tablets for oral suspension containing everolimus. The carton is labeled for 28 tablets, divided into 4 blister cards of 7 tablets each. It states tablets must be dispersed in water and should not be swallowed whole, chewed, or crushed. Manufactured by Novartis Pharmaceuticals Corporation.*

FDA Label Image

Principal Display Panel Ndc 0078-0628-51 Rx Only 28 Tablets For Oral Suspension Carton Contains 4 Individual Blister Cards Of 7 Tablets. Afinitor Disperz® (everolimus Tablets For Oral Suspension) 5 mg Tablets Must Be Dispersed In Water. Tablets Must Not Be Swallowed Whole, Chewed Or Crushed. Each Tablet Contains 5 mg Everolimus Novartis (Afinitor 11)

Packaging label for Afinitor Disperz 5 mg tablets (everolimus tablets for oral suspension) by Novartis Pharmaceuticals Corporation. The carton contains 28 tablets divided into 4 blister cards of 7 tablets each. The label provides dosage form instructions, warnings that tablets must be dispersed in water and not swallowed whole, and indicates the product is Rx only.*

FDA Label Image

Figure 3: Kaplan-meier Progression-free Survival Curves (Afinitor 12)

A Kaplan-Meier survival curve showing probability (%) of event-free status over time in months for patients treated with Everolimus plus Best Supportive Care (BSC) compared to Placebo plus BSC. The graph includes two survival lines and a table below indicating the number of patients still at risk at various time points for each treatment group.*

FDA Label Image

Figure Aa (Afinitor Aa)

An instructional black and white illustration showing a hand stirring a substance in a small transparent cup using a spoon, likely demonstrating how to prepare or mix the medication Afinitor oral tablet for administration.*

FDA Label Image

Figure Bb (Afinitor Bb)

Illustration showing a person drinking from a glass of water, likely demonstrating oral administration of a tablet medication.*

FDA Label Image

Figure Cc (Afinitor Cc)

An instructional illustration showing a hand stirring a spoon inside a small cup containing liquid, likely demonstrating how to dissolve or prepare a tablet for oral administration.*

FDA Label Image

Figure Dd (Afinitor Dd)

An illustration showing a person drinking water from a glass, depicting the action of oral medication administration.*

FDA Label Image

Figure Ee (Afinitor Ee)

A black and white illustration showing a drinking glass and a spoon on a surface, with a faucet above dripping water. This image appears to depict a preparation or administration step involving water, a glass, and a spoon.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.